Duty to RecontactNCT03674879
Impact of Mobile Text Messaging on Follow Up Rates After Discharge From the Pediatric Emergency Department
A study testing Text Message in people with Duty to Recontact, run by New York City Health and Hospitals Corporation.
Trial summary
To compare the effectiveness of text message versus voice call as a method of contact for providing results of diagnostic tests and assuring ongoing care from the pediatric emergency department. Read more about this study
- Who is it for?
- Ages Up to 18 yearsHealthy volunteers can take part
- Conditions the study is for
- Duty to Recontact
- What is being tested?
- Text Message
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- Sep 2016to Dec 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 18 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- patients under the age of 18 who have had diagnostic testing without finalized results prior to discharge from the emergency department
Who cannot join
- Admitted patients
- Patients transferred to another facility
- Patients with critical values as results
- Do not have devices that can receive phone and text messages
- Cannot read English or Spanish
About this study
To compare the effectiveness of text message versus voice call as a method of contact for providing results of diagnostic tests and assuring ongoing care from the pediatric emergency department.
Read the detailed description
The investigators plan to conduct a prospective randomized controlled trial to compare two means of contacting patients and their caregivers after discharge from the emergency department in order to provide results of tests: text messaging (intervention group) vs. telephone call (standard group).
- Conditions
- Duty to Recontact
- Being tested
- Text Message
- Keywords
- Follow Up, Text Messaging
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Text MessageOther
Patient contact attempted with text message.
| Study group | Role | What they receive |
|---|---|---|
| Phone Call | No intervention | Follow up contact is attempted via phone call. |
| Text Message | Experimental | Follow up contact is attempted via text message. Receives: Other: Text Message |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of phone call or text message attempts to successful contact with study participant
A study practitioner will make one attempt per business day to contact the patient or caregiver to provide test results and arrange follow-up care; the method will be determined by the study arm to which the participant is assigned. Participants in the standard practice control arm will receive a telephone call. If a call is not answered, a voice message will be left instructing the patient/parent to call the Pediatric Follow-Up Office. Participants in the intervention arm will receive a text message using the same script. A successful contact will be recorded when a practitioner speaks directly to the patient or parent/guardian via phone.
Measured: Within 2 weeks.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Sep 2018
- Study startSep 2016
- Primary completionAug 2017 (estimated)
- Study completionDec 2017 (estimated)
Why it stopped: PI left facility
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Duty to RecontactStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- New York City Health and Hospitals Corporation
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Czer Anthoney E Lim, MD, Principal investigator, Jacobi Medical Center/Albert Einstein College of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03674879
- Sponsor's protocol ID
- NYCHHC
- Status last verified
- Sep 2018
- First submitted
- 19 Jul 2016
- Last updated
- 18 Sep 2018
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Dudas RA, Pumilia JN, Crocetti M. Pediatric caregiver attitudes and technologic readiness toward electronic follow-up communication in an urban community emergency department. Telemed J E Health. 2013 Jun;19(6):493-6. doi: 10.1089/tmj.2012.0166. Epub 2013 Apr 9.
PubMed 23570276Horne A, Ros SP. Telephone follow-up of patients discharged from the emergency department: how reliable? Pediatr Emerg Care. 1995 Jun;11(3):173-5. doi: 10.1097/00006565-199506000-00008.
PubMed 7651874Levitt MA, Johnson S, Engelstad L, Montana R, Stewart S. Clinical management of chlamydia and gonorrhea infection in a county teaching emergency department--concerns in overtreatment, undertreatment, and follow-up treatment success. J Emerg Med. 2003 Jul;25(1):7-11. doi: 10.1016/s0736-4679(03)00131-8.
PubMed 12865101Neuner B, Fleming M, Born R, Weiss-Gerlach E, Neumann T, Rettig J, Lau A, Schoenfeld H, Kallischnigg G, Spies C. Predictors of loss to follow-up in young patients with minor trauma after screening and written intervention for alcohol in an urban emergency department. J Stud Alcohol Drugs. 2007 Jan;68(1):133-40. doi: 10.15288/jsad.2007.68.133.
PubMed 17149527Reed JL, Huppert JS, Taylor RG, Gillespie GL, Byczkowski TL, Kahn JA, Alessandrini EA. Improving sexually transmitted infection results notification via mobile phone technology. J Adolesc Health. 2014 Nov;55(5):690-7. doi: 10.1016/j.jadohealth.2014.05.004. Epub 2014 Jun 21.
PubMed 24962503Reed JL, Simendinger L, Griffeth S, Kim HG, Huppert JS. Point-of-care testing for sexually transmitted infections increases awareness and short-term abstinence in adolescent women. J Adolesc Health. 2010 Mar;46(3):270-7. doi: 10.1016/j.jadohealth.2009.08.003. Epub 2009 Oct 12.
PubMed 20159505
Study at a glance
From the registry record, last updated by the sponsor on 18 Sep 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Mobile Text Messaging on Follow Up Rates After Discharge From the Pediatric Emergency Department
- ClinicalTrials.gov ID
- NCT03674879
- Acronym / sponsor ID
- NYCHHC
- Conditions
- Duty to Recontact
- Keywords
- Follow Up, Text Messaging
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: PI left facility
- Enrolment
- 0 participants (actual)
- Lead sponsor
- New York City Health and Hospitals CorporationUniversity, hospital or other
- Study start
- Sep 2016
- Primary completion
- Aug 2017 (estimated)
- Study completion
- Dec 2017 (estimated)
- First posted
- 18 Sep 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To compare the effectiveness of text message versus voice call as a method of contact for providing results of diagnostic tests and assuring ongoing care from the pediatric emergency department.
Detailed description
The investigators plan to conduct a prospective randomized controlled trial to compare two means of contacting patients and their caregivers after discharge from the emergency department in order to provide results of tests: text messaging (intervention group) vs. telephone call (standard group).
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Phone Call | No intervention | –Follow up contact is attempted via phone call. |
| Text Message | Experimental | Other: Text MessageFollow up contact is attempted via text message. |
Who may qualify
- Ages
- Up to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (1 listed)
- patients under the age of 18 who have had diagnostic testing without finalized results prior to discharge from the emergency department
Key exclusion criteria (5 listed)
- Admitted patients
- Patients transferred to another facility
- Patients with critical values as results
- Do not have devices that can receive phone and text messages
- Cannot read English or Spanish
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Text MessagePatient contact attempted with text message. | Other | Text Message |
Primary outcome
Number of phone call or text message attempts to successful contact with study participant
Time frame: Within 2 weeks.
A study practitioner will make one attempt per business day to contact the patient or caregiver to provide test results and arrange follow-up care; the method will be determined by the study arm to which the participant is assigned. Participants in the standard practice control arm will receive a telephone call. If a call is not answered, a voice message will be left instructing the patient/parent to call the Pediatric Follow-Up Office. Participants in the intervention arm will receive a text message using the same script. A successful contact will be recorded when a practitioner speaks directly to the patient or parent/guardian via phone.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Sep 2018.
- Background: PubMed 23570276Dudas RA, Pumilia JN, Crocetti M. Pediatric caregiver attitudes and technologic readiness toward electronic follow-up communication in an urban community emergency department. Telemed J E Health. 2013 Jun;19(6):493-6. doi: 10.1089/tmj.2012.0166. Epub 2013 Apr 9.
- Background: PubMed 7651874Horne A, Ros SP. Telephone follow-up of patients discharged from the emergency department: how reliable? Pediatr Emerg Care. 1995 Jun;11(3):173-5. doi: 10.1097/00006565-199506000-00008.
- Background: PubMed 12865101Levitt MA, Johnson S, Engelstad L, Montana R, Stewart S. Clinical management of chlamydia and gonorrhea infection in a county teaching emergency department--concerns in overtreatment, undertreatment, and follow-up treatment success. J Emerg Med. 2003 Jul;25(1):7-11. doi: 10.1016/s0736-4679(03)00131-8.
- Background: PubMed 17149527Neuner B, Fleming M, Born R, Weiss-Gerlach E, Neumann T, Rettig J, Lau A, Schoenfeld H, Kallischnigg G, Spies C. Predictors of loss to follow-up in young patients with minor trauma after screening and written intervention for alcohol in an urban emergency department. J Stud Alcohol Drugs. 2007 Jan;68(1):133-40. doi: 10.15288/jsad.2007.68.133.
- Background: PubMed 24962503Reed JL, Huppert JS, Taylor RG, Gillespie GL, Byczkowski TL, Kahn JA, Alessandrini EA. Improving sexually transmitted infection results notification via mobile phone technology. J Adolesc Health. 2014 Nov;55(5):690-7. doi: 10.1016/j.jadohealth.2014.05.004. Epub 2014 Jun 21.
- Background: PubMed 20159505Reed JL, Simendinger L, Griffeth S, Kim HG, Huppert JS. Point-of-care testing for sexually transmitted infections increases awareness and short-term abstinence in adolescent women. J Adolesc Health. 2010 Mar;46(3):270-7. doi: 10.1016/j.jadohealth.2009.08.003. Epub 2009 Oct 12.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Czer Anthoney E Lim, MD principal investigator
Jacobi Medical Center/Albert Einstein College of Medicine
Questions about this trial
What is this clinical trial studying?
A study testing Text Message in people with Duty to Recontact, run by New York City Health and Hospitals Corporation.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 18 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of phone call or text message attempts to successful contact with study participant (time frame: Within 2 weeks.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03674879, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2018.